Kewaunee Scientific Cash Flow Statement

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Apr '26 Apr 30, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022
Net Income	10.47	11.58	19.06	1.36	-6
Depreciation & Amortization	6.28	4.76	3.13	2.87	2.77
Stock-Based Compensation	2.13	1.44	1.03	0.89	0.73
Other Adjustments	-0.05	-0.98	-6.85	0.64	0.21
Change in Receivables	3.3	-6.74	0.74	-4.95	-8.46
Changes in Inventories	2.32	3.35	1.21	1.91	-7.28
Changes in Accounts Payable	-5.15	0.58	0.69	-5.56	11.89
Changes in Income Taxes Payable	-	-	-	-	0.96
Changes in Unearned Revenue	-1.92	0.77	0.28	0.57	0.41
Changes in Other Operating Activities	1.26	0.02	0.29	-1.51	-3.1
Operating Cash Flow	18.63	14.78	19.56	-3.79	-7.89
Operating Cash Flow Growth	26.04%	-24.44%	-	-	-
Capital Expenditures	-3.94	-2.17	-4.37	-4.15	-1.91
Payments for Business Acquisitions	-	-28.74	-	-	-
Investing Cash Flow	-3.94	-30.9	-4.37	-4.15	-1.91
Short-Term Debt Issued	16.38	73.48	148.06	60.6	59.36
Short-Term Debt Repaid	-17.3	-75.6	-148.55	-58.6	-64.6
Net Short-Term Debt Issued (Repaid)	-0.91	-2.11	-0.49	2	-5.24
Long-Term Debt Issued	10.23	15	0.2	13.63	16.27
Long-Term Debt Repaid	-27.63	-2.12	-0.73	-0.12	-
Net Long-Term Debt Issued (Repaid)	-17.4	12.88	-0.53	13.51	16.27
Repurchase of Common Stock	-	-1.6	-2	-	-
Net Common Stock Issued (Repurchased)	-	-1.6	-2	-	-
Other Financing Activities	-1.01	-1.76	-	-0.58	-
Financing Cash Flow	-19.33	7.41	-3.01	14.93	11.03
Effect of Exchange Rate Changes on Cash and Cash Equivalents	-0.92	-0.07	-0.05	-0.07	-0.08
Net Cash Flow	-5.55	-8.77	12.12	6.92	1.16
Free Cash Flow	14.7	12.62	15.19	-7.94	-9.79
Free Cash Flow Growth	16.48%	-16.94%	-	-	-
FCF Margin	5.21%	5.25%	7.46%	-3.62%	-5.80%
Free Cash Flow Per Share	4.93	4.24	5.17	-2.74	-3.52
Levered Free Cash Flow	-9.85	29.48	18.95	10.37	8.64
Unlevered Free Cash Flow	11.58	21.22	27.77	-4.25	-2.57

SEC Filings: 10-K · 10-Q